Cite
HARVARD Citation
Zhan, C. et al. (2021). A dopamine-precursor-based nanoprodrug for in-situ drug release and treatment of acute liver failure by inhibiting NLRP3 inflammasome and facilitating liver regeneration. Biomaterials. p. . [Online].